GOVX GeoVax Labs | $1.11
-12.6% | 3/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 3/28/2025 |
CLGN CollPlant Biotechnologies | $2.55
-3.8% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | Low | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 3/27/2025 |
EVTL Vertical Aerospace | $3.44
-4.2% | 3/27/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $15.00 | Medium | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 3/27/2025 |
COYA Coya Therapeutics | $6.56
-4.8% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/27/2025 |
HUMA Humacyte | $1.96
-2.5% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/26/2025 |
TTI TETRA Technologies | $3.61
-3.9% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | High | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 3/26/2025 |
ANIX Anixa Biosciences | $2.97
-3.6% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/26/2025 |
CRVO CervoMed | $9.48
+11.5% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/26/2025 |
MVIS MicroVision | $1.21
-6.9% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.00 -> $3.00 | High | View details for D. Boral Capital rating of MicroVision (NASDAQ:MVIS) on 3/25/2025 |
CRMD CorMedix | $6.74
+0.4% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/25/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
QNCX Quince Therapeutics | $1.35
-3.6% | 3/25/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $4.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 3/25/2025 |
NRXP NRx Pharmaceuticals | $2.03
-1.9% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/24/2025 |
IMNN Imunon | $1.09
-4.4% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 3/24/2025 |
CLNN Clene | $3.22
+1.3% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
OMER Omeros | $8.47
-5.0% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 3/21/2025 |
CNTX Context Therapeutics | $0.66
-11.1% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
VNRX VolitionRx | $0.55
+4.2% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/20/2025 |
KAPA Kairos Pharma | $0.92
-5.0% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/20/2025 |
IVVD Invivyd | $0.60
-1.6% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/20/2025 |
TRVI Trevi Therapeutics | $6.50
-0.5% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
BMEA Biomea Fusion | $2.30
-7.6% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 3/19/2025 |
COYA Coya Therapeutics | $6.56
-4.8% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/18/2025 |
RCEL AVITA Medical | $8.73
-5.3% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 3/18/2025 |
CRVO CervoMed | $9.48
+11.5% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/17/2025 |
NRXP NRx Pharmaceuticals | $2.03
-1.9% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/17/2025 |
VERI Veritone | $2.55
-6.9% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/17/2025 |
NOTE FiscalNote | $0.88
-0.6% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.75 -> $3.75 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 3/17/2025 |
MNOV MediciNova | $1.45
-3.3% | 3/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 3/14/2025 |
USEG U.S. Energy | $1.21
-3.2% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 3/13/2025 |
IBRX ImmunityBio | $3.14
-6.5% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Low | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
PED PEDEVCO | $0.70
-2.8% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | Low | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 3/13/2025 |
CLNN Clene | $3.22
+1.3% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
VNRX VolitionRx | $0.55
+4.2% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/12/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-0.9% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
TVGN Tevogen Bio | $1.20
| 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 3/11/2025 |
CRVO CervoMed | $9.48
+11.5% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/11/2025 |
URGN UroGen Pharma | $11.20
-2.2% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 3/10/2025 |
COYA Coya Therapeutics | $6.56
-4.8% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/10/2025 |
CKPT Checkpoint Therapeutics | $4.04
+0.2% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $4.80 | High | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/10/2025 |
LUNG Pulmonx | $6.82
+0.4% | 3/10/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Low | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 3/10/2025 |
URGENT: Someone's Moving Gold Out of London... (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.  Go here to learn about my Top Four picks for the coming bull mania. |
HUMA Humacyte | $1.96
-2.5% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/7/2025 |
TRVI Trevi Therapeutics | $6.50
-0.5% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/7/2025 |
CXDO Crexendo | $5.12
-5.4% | 3/6/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $7.00 -> $10.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 3/6/2025 |
ADUR Aduro Clean Technologies | $5.05
-1.9% | 3/6/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 3/6/2025 |
CRMD CorMedix | $6.74
+0.4% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/5/2025 |
IVVD Invivyd | $0.60
-1.6% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/5/2025 |
VNRX VolitionRx | $0.55
+4.2% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/4/2025 |
TVGN Tevogen Bio | $1.20
| 3/4/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $10.00 | High | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 3/4/2025 |
ENLV Enlivex Therapeutics | $1.02
+1.0% | 3/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/3/2025 |
SCLX Scilex | $0.24
-2.0% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 2/28/2025 |
IBRX ImmunityBio | $3.14
-6.5% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/28/2025 |
FBLG FibroBiologics | $0.95
-6.9% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Low | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/27/2025 |
IMNN Imunon | $1.09
-4.4% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/27/2025 |
GOVX GeoVax Labs | $1.11
-12.6% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 2/27/2025 |
TTI TETRA Technologies | $3.61
-3.9% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 2/27/2025 |
MSAI MultiSensor AI | $1.12
-5.1% | 2/26/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/26/2025 |
IMUX Immunic | $1.20
-3.2% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/26/2025 |
HUMA Humacyte | $1.96
-2.5% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/26/2025 |
KAPA Kairos Pharma | $0.92
-5.0% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/26/2025 |
NOTE FiscalNote | $0.88
-0.6% | 2/25/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.75 | Low | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 2/25/2025 |
NNOX Nano-X Imaging | $5.23
-4.2% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 2/25/2025 |
CMPX Compass Therapeutics | $1.99
-5.2% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 2/25/2025 |
CTSO Cytosorbents | $1.00
| 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2025 |
CLNN Clene | $3.22
+1.3% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/25/2025 |
TRVI Trevi Therapeutics | $6.50
-0.5% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 2/24/2025 |
IVVD Invivyd | $0.60
-1.6% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/24/2025 |
MNOV MediciNova | $1.45
-3.3% | 2/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 2/21/2025 |
OMER Omeros | $8.47
-5.0% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 2/20/2025 |
IMUX Immunic | $1.20
-3.2% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/20/2025 |
RCEL AVITA Medical | $8.73
-5.3% | 2/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $22.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 2/20/2025 |
OSTX OS Therapies | $1.62
| 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 2/20/2025 |
IMNN Imunon | $1.09
-4.4% | 2/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/19/2025 |
CRVO CervoMed | $9.48
+11.5% | 2/19/2025 | Upgraded by | D. Boral Capital | Analyst Jason Kolbert | Hold -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 2/19/2025 |
KAPA Kairos Pharma | $0.92
-5.0% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/18/2025 |
MSAI MultiSensor AI | $1.12
-5.1% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | High | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/18/2025 |
CTXR Citius Pharmaceuticals | $1.55
+19.2% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/18/2025 |
ESLA Estrella Immunopharma | $0.95
+2.0% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 2/18/2025 |
URGN UroGen Pharma | $11.20
-2.2% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 2/18/2025 |
IBRX ImmunityBio | $3.14
-6.5% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/14/2025 |
RCEL AVITA Medical | $8.73
-5.3% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 2/14/2025 |
FBLG FibroBiologics | $0.95
-6.9% | 2/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/13/2025 |
URGN UroGen Pharma | $11.20
-2.2% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 2/12/2025 |
CLGN CollPlant Biotechnologies | $2.55
-3.8% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/12/2025 |
KAPA Kairos Pharma | $0.92
-5.0% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/12/2025 |
AVXL Anavex Life Sciences | $8.72
-8.6% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/12/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-0.9% | 2/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/11/2025 |
ANVS Annovis Bio | $1.65
-11.1% | 2/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | High | View details for D. Boral Capital rating of Annovis Bio (NYSE:ANVS) on 2/10/2025 |
MVIS MicroVision | $1.21
-6.9% | 2/10/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $3.00 | High | View details for D. Boral Capital rating of MicroVision (NASDAQ:MVIS) on 2/10/2025 |
ENLV Enlivex Therapeutics | $1.02
+1.0% | 2/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 2/7/2025 |
VNRX VolitionRx | $0.55
+4.2% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 2/6/2025 |
URGENT: Someone's Moving Gold Out of London... (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania. |
COYA Coya Therapeutics | $6.56
-4.8% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025 |
CLNN Clene | $3.22
+1.3% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/6/2025 |
QNCX Quince Therapeutics | $1.35
-3.6% | 2/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 2/5/2025 |
CLGN CollPlant Biotechnologies | $2.55
-3.8% | 2/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/4/2025 |
IVVD Invivyd | $0.60
-1.6% | 2/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/3/2025 |
VERI Veritone | $2.55
-6.9% | 2/3/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 2/3/2025 |
GOVX GeoVax Labs | $1.11
-12.6% | 1/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/31/2025 |
OSTX OS Therapies | $1.62
| 1/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/30/2025 |
VNRX VolitionRx | $0.55
+4.2% | 1/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/29/2025 |
NRXP NRx Pharmaceuticals | $2.03
-1.9% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/28/2025 |
AVXL Anavex Life Sciences | $8.72
-8.6% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/28/2025 |
IBRX ImmunityBio | $3.14
-6.5% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/27/2025 |
IVVD Invivyd | $0.60
-1.6% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/27/2025 |
SCLX Scilex | $0.24
-2.0% | 1/27/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $22.00 | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 1/27/2025 |
IMNN Imunon | $1.09
-4.4% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 1/24/2025 |
USEG U.S. Energy | $1.21
-3.2% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | Low | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/24/2025 |
URGN UroGen Pharma | $11.20
-2.2% | 1/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/23/2025 |
KAPA Kairos Pharma | $0.92
-5.0% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 1/22/2025 |
ANIX Anixa Biosciences | $2.97
-3.6% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/22/2025 |
CRMD CorMedix | $6.74
+0.4% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/22/2025 |
COYA Coya Therapeutics | $6.56
-4.8% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/21/2025 |
HUMA Humacyte | $1.96
-2.5% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/21/2025 |
RVPH Reviva Pharmaceuticals | $1.01
-7.3% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/21/2025 |
CXDO Crexendo | $5.12
-5.4% | 1/21/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $7.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 1/21/2025 |
OMER Omeros | $8.47
-5.0% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Medium | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 1/16/2025 |
IBRX ImmunityBio | $3.14
-6.5% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/16/2025 |
NOTE FiscalNote | $0.88
-0.6% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 1/16/2025 |
GOVX GeoVax Labs | $1.11
-12.6% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Low | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/16/2025 |
URGN UroGen Pharma | $11.20
-2.2% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 1/15/2025 |
OSTX OS Therapies | $1.62
| 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/15/2025 |
HOVR New Horizon Aircraft | $0.51
-6.8% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | Medium | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/15/2025 |
CNTX Context Therapeutics | $0.66
-11.1% | 1/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 1/15/2025 |
ANIX Anixa Biosciences | $2.97
-3.6% | 1/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/14/2025 |
HUMA Humacyte | $1.96
-2.5% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/13/2025 |
CARM Carisma Therapeutics | $0.33
-7.8% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 1/13/2025 |
AVXL Anavex Life Sciences | $8.72
-8.6% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/13/2025 |
CKPT Checkpoint Therapeutics | $4.04
+0.2% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $9.00 | Medium | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 1/13/2025 |
CRMD CorMedix | $6.74
+0.4% | 1/13/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $15.00 | Low | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/13/2025 |
USEG U.S. Energy | $1.21
-3.2% | 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/13/2025 |
CTSO Cytosorbents | $1.00
| 1/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/13/2025 |
BMEA Biomea Fusion | $2.30
-7.6% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $128.00 -> $128.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 1/10/2025 |
IVVD Invivyd | $0.60
-1.6% | 1/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/10/2025 |
HOVR New Horizon Aircraft | $0.51
-6.8% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | Low | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 1/8/2025 |
VNRX VolitionRx | $0.55
+4.2% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/8/2025 |
CMPX Compass Therapeutics | $1.99
-5.2% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 1/8/2025 |
TRVI Trevi Therapeutics | $6.50
-0.5% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 1/8/2025 |
TTI TETRA Technologies | $3.61
-3.9% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 1/8/2025 |
RCEL AVITA Medical | $8.73
-5.3% | 1/8/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 1/8/2025 |
CTXR Citius Pharmaceuticals | $1.55
+19.2% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 1/7/2025 |
IMUX Immunic | $1.20
-3.2% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 1/7/2025 |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
AREC American Resources | $0.49
-7.5% | 1/7/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | Low | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 1/7/2025 |
IBRX ImmunityBio | $3.14
-6.5% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/6/2025 |
NRXP NRx Pharmaceuticals | $2.03
-1.9% | 1/6/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/6/2025 |
NNOX Nano-X Imaging | $5.23
-4.2% | 1/6/2025 | Initiated by | D. Boral Capital | - | Buy | $23.00 | N/A | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 1/6/2025 |
CTSO Cytosorbents | $1.00
| 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 1/3/2025 |
LCTX Lineage Cell Therapeutics | $0.49
-0.9% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 1/3/2025 |
USEG U.S. Energy | $1.21
-3.2% | 1/3/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/3/2025 |
QNCX Quince Therapeutics | $1.35
-3.6% | 1/2/2025 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 1/2/2025 |
NRXP NRx Pharmaceuticals | $2.03
-1.9% | 12/31/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 12/31/2024 |
HOVR New Horizon Aircraft | $0.51
-6.8% | 12/30/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 12/30/2024 |
CTXR Citius Pharmaceuticals | $1.55
+19.2% | 12/30/2024 | Upgraded by | D. Boral Capital | - | Hold -> Buy | $9.00 | N/A | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 12/30/2024 |
FBLG FibroBiologics | $0.95
-6.9% | 12/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 12/27/2024 |
RCEL AVITA Medical | $8.73
-5.3% | 12/24/2024 | Initiated by | D. Boral Capital | - | Buy | $25.00 | N/A | View details for D. Boral Capital rating of AVITA Medical (NASDAQ:RCEL) on 12/24/2024 |
AVXL Anavex Life Sciences | $8.72
-8.6% | 12/23/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 12/23/2024 |
CMPX Compass Therapeutics | $1.99
-5.2% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $32.00 | N/A | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 12/23/2024 |
OMER Omeros | $8.47
-5.0% | 12/23/2024 | Initiated by | D. Boral Capital | - | Buy | $36.00 | N/A | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 12/23/2024 |
IBRX ImmunityBio | $3.14
-6.5% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 12/20/2024 |
RZLV Rezolve AI | $1.31
-8.4% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for D. Boral Capital rating of Rezolve AI (NASDAQ:RZLV) on 12/20/2024 |
HUMA Humacyte | $1.96
-2.5% | 12/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
IMNN Imunon | $1.09
-4.4% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
CLNN Clene | $3.22
+1.3% | 12/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/19/2024 |
COYA Coya Therapeutics | $6.56
-4.8% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/18/2024 |
GOVX GeoVax Labs | $1.11
-12.6% | 12/18/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 12/18/2024 |
TTI TETRA Technologies | $3.61
-3.9% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.50 -> $5.50 | N/A | View details for D. Boral Capital rating of TETRA Technologies (NYSE:TTI) on 12/17/2024 |
BMEA Biomea Fusion | $2.30
-7.6% | 12/17/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/17/2024 |
ICFI ICF International | $86.17
+0.2% | 12/16/2024 | Reiterated by | D. Boral Capital | - | Outperform -> Outperform | $174.00 -> $174.00 | N/A | View details for D. Boral Capital rating of ICF International (NASDAQ:ICFI) on 12/16/2024 |
TRVI Trevi Therapeutics | $6.50
-0.5% | 12/12/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/12/2024 |
ENLV Enlivex Therapeutics | $1.02
+1.0% | 12/11/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/11/2024 |
CLNN Clene | $3.22
+1.3% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 12/10/2024 |
VNRX VolitionRx | $0.55
+4.2% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 12/10/2024 |
IMNN Imunon | $1.09
-4.4% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 12/10/2024 |
CRVO CervoMed | $9.48
+11.5% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 12/10/2024 |
BMEA Biomea Fusion | $2.30
-7.6% | 12/10/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 12/10/2024 |
CARM Carisma Therapeutics | $0.33
-7.8% | 12/9/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $24.00 -> $12.00 | N/A | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 12/9/2024 |
URGN UroGen Pharma | $11.20
-2.2% | 12/6/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of UroGen Pharma (NASDAQ:URGN) on 12/6/2024 |
TRVI Trevi Therapeutics | $6.50
-0.5% | 12/4/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/4/2024 |
COYA Coya Therapeutics | $6.56
-4.8% | 12/4/2024 | Initiated by | D. Boral Capital | - | Buy | $15.00 | N/A | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 12/4/2024 |
ENLV Enlivex Therapeutics | $1.02
+1.0% | 12/3/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 12/3/2024 |
MNOV MediciNova | $1.45
-3.3% | 12/2/2024 | Initiated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 12/2/2024 |
CRVO CervoMed | $9.48
+11.5% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $34.00 -> $34.00 | N/A | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 11/27/2024 |
CLGN CollPlant Biotechnologies | $2.55
-3.8% | 11/27/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/27/2024 |
AVXL Anavex Life Sciences | $8.72
-8.6% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $46.00 -> $46.00 | N/A | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/25/2024 |
IMNN Imunon | $1.09
-4.4% | 11/25/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $29.00 -> $29.00 | N/A | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 11/25/2024 |
GOVX GeoVax Labs | $1.11
-12.6% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 11/19/2024 |
ANIX Anixa Biosciences | $2.97
-3.6% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 11/19/2024 |
BMEA Biomea Fusion | $2.30
-7.6% | 11/19/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $128.00 -> $128.00 | N/A | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 11/19/2024 |
PED PEDEVCO | $0.70
-2.8% | 11/20/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $2.25 -> $1.50 | N/A | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 11/20/2024 |
FBLG FibroBiologics | $0.95
-6.9% | 11/20/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 11/20/2024 |
LCTX Lineage Cell Therapeutics | $0.49
-0.9% | 11/20/2024 | Target Lowered by | D. Boral Capital | - | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 11/20/2024 |
IVVD Invivyd | $0.60
-1.6% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 11/21/2024 |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
HUMA Humacyte | $1.96
-2.5% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 11/21/2024 |
IBRX ImmunityBio | $3.14
-6.5% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 11/21/2024 |
AREC American Resources | $0.49
-7.5% | 11/21/2024 | Reiterated by | D. Boral Capital | - | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for D. Boral Capital rating of American Resources (NASDAQ:AREC) on 11/21/2024 |
CTXR Citius Pharmaceuticals | $1.55
+19.2% | 11/22/2024 | Reiterated by | D. Boral Capital | - | Buy -> Hold | | N/A | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 11/22/2024 |
CNTX Context Therapeutics | $0.66
-11.1% | 11/25/2024 | Initiated by | D. Boral Capital | - | Buy | $9.00 | N/A | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 11/25/2024 |
